Your browser doesn't support javascript.
loading
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy, Nicholas A; Goodhand, James R; Bewshea, Claire; Nice, Rachel; Chee, Desmond; Lin, Simeng; Chanchlani, Neil; Butterworth, Jeffrey; Cooney, Rachel; Croft, Nicholas M; Hart, Ailsa L; Irving, Peter M; Kok, Klaartje B; Lamb, Christopher A; Limdi, Jimmy K; Macdonald, Jonathan; McGovern, Dermot Pb; Mehta, Shameer J; Murray, Charles D; Patel, Kamal V; Pollok, Richard Cg; Raine, Timothy; Russell, Richard K; Selinger, Christian P; Smith, Philip J; Bowden, Jack; McDonald, Timothy J; Lees, Charlie W; Sebastian, Shaji; Powell, Nicholas; Ahmad, Tariq.
Afiliação
  • Kennedy NA; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Goodhand JR; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Bewshea C; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Nice R; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Chee D; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Lin S; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Chanchlani N; Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Butterworth J; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Cooney R; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Croft NM; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Hart AL; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Irving PM; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Kok KB; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Lamb CA; Department of Gastroenterology, Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK.
  • Limdi JK; Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Macdonald J; Department of Paediatric Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • McGovern DP; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK.
  • Mehta SJ; Department of Gastroenterology, St Mark's Hospital and Academic Institute, Harrow, London, UK.
  • Murray CD; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Patel KV; School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Pollok RC; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK.
  • Raine T; Department of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Russell RK; Department of Gastroenterology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • Selinger CP; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Smith PJ; Department of Gastroenterology, Pennine Acute Hospitals NHS Trust, Manchester, UK.
  • Bowden J; Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.
  • McDonald TJ; Department of Gastroenterology, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.
  • Lees CW; F. Widjaja Foundation Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Sebastian S; Department of Gastroenterology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Powell N; Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, UK.
  • Ahmad T; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK.
Gut ; 70(5): 865-875, 2021 05.
Article em En | MEDLINE | ID: mdl-33753421
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Infliximab / SARS-CoV-2 / Anticorpos Antivirais / Formação de Anticorpos Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Gut Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Infliximab / SARS-CoV-2 / Anticorpos Antivirais / Formação de Anticorpos Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Gut Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido